Early Detection of Biomarkers for Disease
Seiten
2017
Royal Society of Chemistry (Verlag)
978-1-84973-613-8 (ISBN)
Royal Society of Chemistry (Verlag)
978-1-84973-613-8 (ISBN)
- Titel wird leider nicht erscheinen
- Artikel merken
Many diseases can now be diagnosed at the sub-clinical level thanks to the identification of specific biomarkers, which often occur in concentrations close to the limit of detection of existing technologies.
While much of the literature examines specific biomarkers in the context of specific diseases, this book focusses on the detection of known biomarkers; demonstrating how the adaptation of existing techniques with the latest technological advances can identify the early onset of illnesses such as diabetes, leukaemia, Alzheimer's, and cardiac disease.
The volume editors represent both academia and industry, and have drawn together contributions from researchers and clinicians. The first half of the book presents the latest technologies available, incorporating emerging fields such as genomics and metabolomics. Point-of-care systems for disease diagnosis are also discussed. Chapters in the second half of the book are dedicated to specific diseases.
With its unique approach to the topic, and input from all sectors involved, this book will prove invaluable to anyone wishing to see how modern detection science is assisting in the battle against disease, and how the tools available today can be improved for tomorrow.
While much of the literature examines specific biomarkers in the context of specific diseases, this book focusses on the detection of known biomarkers; demonstrating how the adaptation of existing techniques with the latest technological advances can identify the early onset of illnesses such as diabetes, leukaemia, Alzheimer's, and cardiac disease.
The volume editors represent both academia and industry, and have drawn together contributions from researchers and clinicians. The first half of the book presents the latest technologies available, incorporating emerging fields such as genomics and metabolomics. Point-of-care systems for disease diagnosis are also discussed. Chapters in the second half of the book are dedicated to specific diseases.
With its unique approach to the topic, and input from all sectors involved, this book will prove invaluable to anyone wishing to see how modern detection science is assisting in the battle against disease, and how the tools available today can be improved for tomorrow.
Part 1: Technology for early detection of biomarkers; Mass Spectrometry, Fluorescently Activated Cell Sorting; Metabolomics; Genomics; Point of Care Systems; Part 2: Early biomarkers of disease; Cardiac Diseases; Diabetes; Leukaemia; Cancer; Alzheimier's Disease
| Erscheint lt. Verlag | 26.6.2017 |
|---|---|
| Reihe/Serie | Detection Science |
| Zusatzinfo | No |
| Verlagsort | Cambridge |
| Sprache | englisch |
| Maße | 156 x 234 mm |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete |
| Naturwissenschaften ► Biologie ► Genetik / Molekularbiologie | |
| Naturwissenschaften ► Chemie ► Analytische Chemie | |
| Technik ► Umwelttechnik / Biotechnologie | |
| ISBN-10 | 1-84973-613-8 / 1849736138 |
| ISBN-13 | 978-1-84973-613-8 / 9781849736138 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Theorien, Modelle, Methoden
Buch | Softcover (2024)
Springer Fachmedien (Verlag)
CHF 34,90
